Expression of PD-L1 and PD-L2 in lung cancer tumors is known to be heterogeneous, with some patients expressing a high proportion of tumor cells positive for these markers while others have no detectable PD-L1 and PD-L2 [30]. This evidence concerns the gene CD274 and neoplasm.